Nonetheless, in patients with tau deposition, we found metabolic dysregulation and numerous pathways related to altered signaling and ERBB family genes, which encode for tyrosine kinase receptors and have been identified as risk factors for developing ALS or FTD [72]. This evidence concerns the gene EGFR and amyotrophic lateral sclerosis.